These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
240 related articles for article (PubMed ID: 26047769)
1. The effect of the antipsychotic drug quetiapine and its metabolite norquetiapine on acute inflammation, memory and anhedonia. Jaehne EJ; Corrigan F; Toben C; Jawahar MC; Baune BT Pharmacol Biochem Behav; 2015 Aug; 135():136-44. PubMed ID: 26047769 [TBL] [Abstract][Full Text] [Related]
2. Quetiapine and its metabolite norquetiapine: translation from in vitro pharmacology to in vivo efficacy in rodent models. Cross AJ; Widzowski D; Maciag C; Zacco A; Hudzik T; Liu J; Nyberg S; Wood MW Br J Pharmacol; 2016 Jan; 173(1):155-66. PubMed ID: 26436896 [TBL] [Abstract][Full Text] [Related]
3. Effects of norquetiapine, the active metabolite of quetiapine, on cloned hERG potassium channels. Lee HJ; Choi JS; Choi BH; Hahn SJ Neurosci Lett; 2018 Jan; 664():66-73. PubMed ID: 29133173 [TBL] [Abstract][Full Text] [Related]
4. Chronic mild stress and imipramine treatment elicit opposite changes in behavior and in gene expression in the mouse prefrontal cortex. Erburu M; Cajaleon L; Guruceaga E; Venzala E; Muñoz-Cobo I; Beltrán E; Puerta E; Tordera RM Pharmacol Biochem Behav; 2015 Aug; 135():227-36. PubMed ID: 26051025 [TBL] [Abstract][Full Text] [Related]
5. Role of concomitant inhibition of the norepinephrine transporter for the antipsychotic effect of quetiapine. Björkholm C; Jardemark K; Marcus MM; Malmerfelt A; Nyberg S; Schilström B; Svensson TH Eur Neuropsychopharmacol; 2013 Jul; 23(7):709-20. PubMed ID: 22732518 [TBL] [Abstract][Full Text] [Related]
6. Effect of quetiapine and norquetiapine on anxiety and depression in major psychoses using a pharmacokinetic approach: a prospective observational study. Altamura AC; Moliterno D; Paletta S; Buoli M; Dell'osso B; Mauri MC; Bareggi SR Clin Drug Investig; 2012 Mar; 32(3):213-9. PubMed ID: 22299714 [TBL] [Abstract][Full Text] [Related]
7. Norquetiapine blocks the human cardiac sodium channel Na Kim DH; Park KS; Park SH; Hahn SJ; Choi JS Eur J Pharmacol; 2020 Oct; 885():173532. PubMed ID: 32882214 [TBL] [Abstract][Full Text] [Related]
8. Time course of the effects of lipopolysaccharide on prepulse inhibition and brain nitrite content in mice. Custódio CS; Mello BS; Cordeiro RC; de Araújo FY; Chaves JH; Vasconcelos SM; Nobre Júnior HV; de Sousa FC; Vale ML; Carvalho AF; Macêdo DS Eur J Pharmacol; 2013 Aug; 713(1-3):31-8. PubMed ID: 23665499 [TBL] [Abstract][Full Text] [Related]
9. Chronic pubertal cannabinoid treatment as a behavioural model for aspects of schizophrenia: effects of the atypical antipsychotic quetiapine. Leweke FM; Schneider M Int J Neuropsychopharmacol; 2011 Feb; 14(1):43-51. PubMed ID: 20678304 [TBL] [Abstract][Full Text] [Related]
10. Quetiapine attenuates recognition memory impairment and hippocampal oxidative stress in a transgenic mouse model of Alzheimer's disease. Luo G; Liu M; He J; Guo H; Xue M; Wang X; Li XM Neuroreport; 2014 Jun; 25(9):647-50. PubMed ID: 24642954 [TBL] [Abstract][Full Text] [Related]
12. The atypical antipsychotic quetiapine increases both noradrenaline and dopamine release in the rat prefrontal cortex. Pira L; Mongeau R; Pani L Eur J Pharmacol; 2004 Nov; 504(1-2):61-4. PubMed ID: 15507222 [TBL] [Abstract][Full Text] [Related]
13. Lentivirus-mediated interleukin-1β (IL-1β) knock-down in the hippocampus alleviates lipopolysaccharide (LPS)-induced memory deficits and anxiety- and depression-like behaviors in mice. Li M; Li C; Yu H; Cai X; Shen X; Sun X; Wang J; Zhang Y; Wang C J Neuroinflammation; 2017 Sep; 14(1):190. PubMed ID: 28931410 [TBL] [Abstract][Full Text] [Related]
14. The effect of atypical antipsychotics, perospirone, ziprasidone and quetiapine on microglial activation induced by interferon-gamma. Bian Q; Kato T; Monji A; Hashioka S; Mizoguchi Y; Horikawa H; Kanba S Prog Neuropsychopharmacol Biol Psychiatry; 2008 Jan; 32(1):42-8. PubMed ID: 17716796 [TBL] [Abstract][Full Text] [Related]
15. Honokiol abrogates lipopolysaccharide-induced depressive like behavior by impeding neuroinflammation and oxido-nitrosative stress in mice. Sulakhiya K; Kumar P; Jangra A; Dwivedi S; Hazarika NK; Baruah CC; Lahkar M Eur J Pharmacol; 2014 Dec; 744():124-31. PubMed ID: 25446914 [TBL] [Abstract][Full Text] [Related]
16. The preclinical discovery and development of quetiapine for the treatment of mania and depression. Miranda AS; Moreira FA; Teixeira AL Expert Opin Drug Discov; 2017 May; 12(5):525-535. PubMed ID: 28271741 [TBL] [Abstract][Full Text] [Related]
17. Changes in behaviour and cytokine expression upon a peripheral immune challenge. Bay-Richter C; Janelidze S; Hallberg L; Brundin L Behav Brain Res; 2011 Sep; 222(1):193-9. PubMed ID: 21466824 [TBL] [Abstract][Full Text] [Related]
18. Effects of quetiapine on behavioral changes and expression of myelin proteins in a chronic alcohol dependence rat model. Han J; Wang G; Liu M; Chai R; Guo J; Zhang F; Lu C; Zhang Y; Wang H; Zhang R Behav Brain Res; 2020 May; 385():112561. PubMed ID: 32070690 [TBL] [Abstract][Full Text] [Related]
19. Lipopolysaccharide induced anxiety- and depressive-like behaviour in mice are prevented by chronic pre-treatment of esculetin. Sulakhiya K; Keshavlal GP; Bezbaruah BB; Dwivedi S; Gurjar SS; Munde N; Jangra A; Lahkar M; Gogoi R Neurosci Lett; 2016 Jan; 611():106-11. PubMed ID: 26620836 [TBL] [Abstract][Full Text] [Related]
20. Soluble interleukin-2 receptor levels correlated with positive symptoms during quetiapine treatment in schizophrenia-spectrum disorders. Igue R; Potvin S; Bah R; Stip E; Bouchard RH; Lipp O; Gendron A; Kouassi E Prog Neuropsychopharmacol Biol Psychiatry; 2011 Aug; 35(7):1695-8. PubMed ID: 21627977 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]